A detailed history of Point72 (Difc) LTD transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 12,129 shares of DVAX stock, worth $120,683. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,129
Previous 8,305 46.04%
Holding current value
$120,683
Previous $106 Million 48.34%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$12.39 - $14.4 $47,379 - $55,065
3,824 Added 46.04%
12,129 $157 Million
Q4 2024

Feb 14, 2025

BUY
$10.28 - $13.66 $85,375 - $113,446
8,305 New
8,305 $106 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.26B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.